RefBan

Referral Banners

Yashi

Wednesday, July 24, 2013

Deals Today

Click to View in Browser
07/24/2013
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
Dell shareholders convene again to vote on founder's buyout offer
ROUND ROCK, Texas (Reuters) - Dell Inc shareholders converge on Texas on Wednesday to vote on CEO Michael Dell's $24.4 billion buyout offer for the company after a previous meeting was pushed back a week in the hope of convincing dubious investors to accept the deal.
Hanesbrands to buy underwear rival Maidenform Brands
(Reuters) - Hanesbrands Inc , whose labels include the Wonderbra, said it will buy lingerie company Maidenform Brands Inc for $547 million to boost its product line up.
Immofinanz delays Buwog IPO because of weak market
VIENNA (Reuters) - Austrian property group Immofinanz is unlikely to list its residential property unit Buwog as planned this year because of a weak market environment, a company spokeswoman said.
Hess Corp in China's first shale oil development deal
BEIJING (Reuters) - U.S. energy company Hess Corp has sealed a production sharing contract with China National Petroleum Company (CNPC) to develop a shale oil block in the Xinjiang region, in China's first such agreement on the unconventional oil, the companies said on Wednesday.
Sanofi, Carlyle in talks to buy Elder Pharma's India formulations business: sources
(Reuters) - Sanofi SA's India unit and Carlyle Group are in separate talks to buy the domestic drug formulations business of India's Elder Pharmaceuticals Ltd for $400 million-$450 million, three sources with direct knowledge of the matter said.
IDB in talks to sell 30 pct of Clal Insurance to Chinese group
TEL AVIV (Reuters) - Israeli holding company IDB Development is in advanced talks to sell a 30 percent stake in Clal Insurance to a group of investors based in China at a company valuation of 4.6 billion shekels ($1.3 billion).
South Africa's Aspen Pharmacare values GSK deal at 700 million pounds
JOHANNESBURG (Reuters) - South Africa's Aspen Pharmacare Holdings on Wednesday valued its bid for two of GlaxoSmithKline's thrombosis drugs and a French factory at around 700 million pounds sterling, 100 million pounds of which will be for inventory.
UK 'bad bank' sells Northern Rock loan portfolio
LONDON (Reuters) - Britain's state-run 'bad bank' has agreed to sell a portfolio of former Northern Rock loans to U.S. private equity firm J.C. Flowers and debt recovery business Marlin Financial for a combined 400 million pounds ($615 million).
SMBC to buy SocGen's Japan private banking business
TOKYO/PARIS (Reuters) - Sumitomo Mitsui Banking Corp (SMBC) said on Wednesday it has agreed to buy Societe Generale's private banking business in Japan for an undisclosed sum.
Analysis: Argentina shows new pragmatism with Chevron deal
BUENOS AIRES (Reuters) - After years of nationalist rhetoric and protectionist policies, Argentina is seeking to lure foreign investment to its Vaca Muerta shale oil and gas field in an bid to jumpstart the country's energy sector and reverse a decline in output.
Related Video
Breakingviews: Inconsistency, not zealotry troubles BoE
Reuters Today: GSK CEO feels heat, China PMIs cool
Related News
Obama eyeing Fed's Raskin for No. two post at Treasury: source
Mortgage rates fall for first time since May: MBA
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
Daily Investor Update
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
 Before the Bell
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments:

Yashi

Chitika